Lab-Made ‘Miniproteins’ Could Block the Coronavirus from Infecting Cells
Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce
Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce
A stretch of Neandertal DNA has been associated with some cases of severe COVID-19, but it’s unclear how much of a risk it poses. Christopher Intagliata reports.
China has promised vaccines to many countries, but whether it can meet its commitments is unclear
New Nobel laureate in chemistry Jennifer Doudna talks about various applications of the gene-editing tool CRISPR.
Charles Rice, who today shared the Nobel Prize in Physiology or Medicine for the discovery of the hepatitis C virus, talked about how rapidly research now occurs, compared with his early work...
Harvey J. Alter, Michael Houghton and Charles M. Rice share the award for identifying the virus behind the blood-borne liver disease
Proponents say yes, but scientific studies on the effectiveness of this chemical derived from cannabis are a mixed bag
Experts explain why getting vaccinated is important every year—and especially during a pandemic
Advisory groups around the world have released guidance to prioritize healthcare workers and those in front-line jobs
The test was halted when a participant suffered spinal cord damage, and U.S. scientists launched an investigation
U.K. trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released
Scientists urge caution in the global vaccine race as AstraZeneca reports an “adverse event” in a person who received the University of Oxford vaccine
After neutralizing SARS-CoV-2 in cell culture, scientists at the University of Costa Rica are proceeding with human testing
The Trump administration’s Operation Warp Speed program is backing six efforts with the ambitious goal of delivering an effective vaccine by January
Medical ethicist Ezekiel Emanuel discusses a framework for equitably allocating COVID-19 vaccines based on preventing premature deaths and mitigating long-term economic impacts
The results of a trial that found dexamethasone reduced the risk of death in extremely ill coronavirus patients have yet to be published, but some doctors are already embracing them
Vaccines and drugs drove a century of progress, but today’s contagions thrive on inequality
It could be the second human disease we eradicate—but if we don’t finish the job, resurgence is possible
Despite calls for more rigorous clinical trials, the Food and Drug Administration has granted an emergency authorization for the therapy
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account